Rezolute (RZLT) Profit After Tax (2010 - 2026)
Rezolute (RZLT) posted Profit After Tax of -$16.3 million for Q1 2026, up 28.29% sequentially from -$22.8 million in Q4 2025, and up 13.65% YoY from -$14.4 million in Q1 2025.
Rezolute (RZLT) Profit After Tax (2010 - 2026) Analysis & Trends
Rezolute has reported Profit After Tax for 17 years, with the latest figure at -$16.3 million in Q1 2026.
- Quarterly Profit After Tax rose 13.65% year-over-year to -$16.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$81.8 million (down 12.99% YoY) and the FY2025 annual result came in at -$74.4 million, down 9.11% from the prior year.
- Profit After Tax advanced to -$16.3 million in Q1 2026 per RZLT's latest filing, from -$22.8 million in the prior quarter.
- Over five years, Profit After Tax peaked at -$9.4 million in Q2 2022 and troughed at -$24.5 million in Q2 2025.
- A 5-year average of -$16.0 million and a median of -$15.7 million in 2024 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2026: Profit After Tax sank 203.33% in 2022, then increased 13.65% in 2026.
- Over 5 years, Profit After Tax stood at -$13.6 million in 2022, then decreased by 0.86% to -$13.7 million in 2023, then fell by 15.04% to -$15.7 million in 2024, then slumped by 44.79% to -$22.8 million in 2025, then rose by 28.29% to -$16.3 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$16.3 million, -$22.8 million, and -$18.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - | -16.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.33 Mn |
| Dec 31, 2025 | -22.78 Mn |
| Sep 30, 2025 | -18.15 Mn |
| Jun 30, 2025 | -24.50 Mn |
| Mar 31, 2025 | -18.91 Mn |
| Dec 31, 2024 | -15.73 Mn |
| Sep 30, 2024 | -15.01 Mn |
| Jun 30, 2024 | -22.70 Mn |
| Mar 31, 2024 | -17.05 Mn |
| Dec 31, 2023 | -13.67 Mn |
| Sep 30, 2023 | -14.52 Mn |
| Jun 30, 2023 | -12.60 Mn |
| Mar 31, 2023 | -15.80 Mn |
| Dec 31, 2022 | -13.56 Mn |
| Sep 30, 2022 | -9.83 Mn |
| Jun 30, 2022 | -9.42 Mn |
| Mar 31, 2022 | -11.21 Mn |
| Dec 31, 2021 | -12.59 Mn |
| Sep 30, 2021 | -7.84 Mn |
| Jun 30, 2021 | -6.49 Mn |